BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38255973)

  • 21. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
    J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
    Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
    Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperaldosteronism: the internist's hypertensive disease.
    Brown CA; Bouldin MJ; Blackston JW; Duddleston DN; Shepherd JM; Hicks GS
    Am J Med Sci; 2002 Oct; 324(4):227-31. PubMed ID: 12385496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
    Piaditis G; Markou A; Papanastasiou L; Androulakis II; Kaltsas G
    Eur J Endocrinol; 2015 May; 172(5):R191-203. PubMed ID: 25538205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress in the diagnosis and treatment of primary aldosteronism.
    Yoshida Y; Shibata H
    Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary aldosteronism: emerging trends.
    Galati SJ; Hopkins SM; Cheesman KC; Zhuk RA; Levine AC
    Trends Endocrinol Metab; 2013 Sep; 24(9):421-30. PubMed ID: 23796656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primay hyperaldosteronism--diagnostic and treatment].
    Potthoff SA; Beuschlein F; Vonend O
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
    Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R
    Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnosis and therapy of primary aldosteronism: new aspects].
    Asbach E; Reincke M
    Dtsch Med Wochenschr; 2022 Jan; 147(3):92-97. PubMed ID: 35100641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who should be screened for primary aldosteronism? A comprehensive review of current evidence.
    Huang WC; Lin YH; Wu VC; Chen CH; Siddique S; Chia YC; Tay JC; Sogunuru G; Cheng HM; Kario K
    J Clin Hypertens (Greenwich); 2022 Sep; 24(9):1194-1203. PubMed ID: 36196469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of aldosterone in hypertension].
    Vonend O; Quack I; Rump LC
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):65-74. PubMed ID: 20213371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fifty years of subclinical primary aldosteronism: importance of early diagnosis].
    Ćirić J; Žarković M; Beleslin B
    Srp Arh Celok Lek; 2012; 140(11-12):800-5. PubMed ID: 23350260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis.
    Bardet S; Chamontin B; Douillard C; Pagny JY; Hernigou A; Joffre F; Plouin PF; Steichen O
    Ann Endocrinol (Paris); 2016 Jul; 77(3):208-13. PubMed ID: 27036860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.